Description
Composition- Levocetirizine 2.5 mg + Montelukast 4 mg Dispersible
Mode of Action- Combines H1 receptor blockade with leukotriene antagonism to reduce allergy symptoms and airway inflammation in children.
USPs- Kid-friendly dispersible format; dual allergy pathway control; useful in pediatric allergic rhinitis.
Prescribing Specialties- Pediatrician, General Physician
